Literature DB >> 2213015

Enzyme activities in relation to pH and lactate in postmortem brain in Alzheimer-type and other dementias.

C M Yates1, J Butterworth, M C Tennant, A Gordon.   

Abstract

Phosphate-activated glutaminase, glutamic acid decarboxylase, pyruvate dehydrogenase, succinic dehydrogenase, pH, and lactate were measured in frontal cortex and caudate nucleus of postmortem brains from cases of Alzheimer-type dementia (ATD), Down's syndrome, Huntington's disease, and one case of Pick's disease, as well as from sudden death and agonal controls. Lactate levels were higher and pH, phosphate-activated glutaminase, and glutamic acid decarboxylase levels were lower in the agonal controls than in the sudden death controls. Phosphate-activated glutaminase and glutamic acid decarboxylase were correlated with tissue pH and lactate, and also were reduced by in vitro acidification, suggesting that the low activities of these enzymes in agonal controls were related to decreased pH consequent upon lactate accumulation. Compared with control tissues at the same pH, phosphate-activated glutaminase and glutamic acid decarboxylase were unaltered in ATD and Down's frontal cortex and reduced in Huntington's caudate nucleus, and glutamic acid decarboxylase was reduced in Huntington's frontal cortex. These data suggest that GABAergic neurons are not affected in ATD and confirm the GABAergic defect in Huntington's disease. Pyruvate dehydrogenase and succinic dehydrogenase activities were the same in agonal controls and sudden death controls and were unaffected by acid pH and lactate in vitro, and pyruvate dehydrogenase was not correlated with pH or lactate. Reduced pyruvate dehydrogenase in frontal cortex of individual ATD, Down's, and Pick's cases, and in the caudate nucleus of Huntington's and Down's cases, was accompanied by gliosis/neuron loss. We conclude that decreased pyruvate dehydrogenase reflects neuronal loss.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2213015     DOI: 10.1111/j.1471-4159.1990.tb04948.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  53 in total

Review 1.  Acidosis, acid-sensing ion channels, and neuronal cell death.

Authors:  Yi-Zhi Wang; Tian-Le Xu
Journal:  Mol Neurobiol       Date:  2011-09-20       Impact factor: 5.590

2.  A kinetic model for beta-amyloid adsorption at the air/solution interface and its implication to the beta-amyloid aggregation process.

Authors:  Dianlu Jiang; Kim Lien Dinh; Travis C Ruthenburg; Yi Zhang; Lei Su; Donald P Land; Feimeng Zhou
Journal:  J Phys Chem B       Date:  2009-03-12       Impact factor: 2.991

Review 3.  Estrogen: a master regulator of bioenergetic systems in the brain and body.

Authors:  Jamaica R Rettberg; Jia Yao; Roberta Diaz Brinton
Journal:  Front Neuroendocrinol       Date:  2013-08-29       Impact factor: 8.606

4.  Biomarkers of HIV-1-associated neurocognitive disorders: challenges of proteomic approaches.

Authors:  Pawel Ciborowski
Journal:  Biomark Med       Date:  2009-12       Impact factor: 2.851

5.  Improved workflow for mass spectrometry-based metabolomics analysis of the heart.

Authors:  Douglas A Andres; Lyndsay E A Young; Sudhakar Veeranki; Tara R Hawkinson; Bryana M Levitan; Daheng He; Chi Wang; Jonathan Satin; Ramon C Sun
Journal:  J Biol Chem       Date:  2020-01-24       Impact factor: 5.157

6.  Tautomeric Effect of Histidine on β-Sheet Formation of Amyloid Beta 1-40: 2D-IR Simulations.

Authors:  Yeonsig Nam; Mahroof Kalathingal; Shinji Saito; Jin Yong Lee
Journal:  Biophys J       Date:  2020-07-18       Impact factor: 4.033

Review 7.  Alzheimer's disease: cerebrovascular dysfunction, oxidative stress, and advanced clinical therapies.

Authors:  Michael W Marlatt; Paul J Lucassen; George Perry; Mark A Smith; Xiongwei Zhu
Journal:  J Alzheimers Dis       Date:  2008-10       Impact factor: 4.472

Review 8.  Mitochondrial abnormalities in Alzheimer's disease: possible targets for therapeutic intervention.

Authors:  Diana F Silva; J Eva Selfridge; Jianghua Lu; Lezi E; Sandra M Cardoso; Russell H Swerdlow
Journal:  Adv Pharmacol       Date:  2012

9.  Treatment advances in Alzheimer's disease based on the oxidative stress model.

Authors:  Avi L Friedlich; Raj K Rolston; Xiongwei Zhu; Michael W Marlatt; Rudy J Castellani; Akihiko Nunomura; Hyoung-Gon Lee; Gemma Casadesus; George Perry; Mark A Smith
Journal:  F1000 Med Rep       Date:  2009-07-08

10.  Intracellular amyloid formation in muscle cells of Abeta-transgenic Caenorhabditis elegans: determinants and physiological role in copper detoxification.

Authors:  Alicia N Minniti; Daniela L Rebolledo; Paula M Grez; Ricardo Fadic; Rebeca Aldunate; Irene Volitakis; Robert A Cherny; Carlos Opazo; Colin Masters; Ashley I Bush; Nibaldo C Inestrosa
Journal:  Mol Neurodegener       Date:  2009-01-06       Impact factor: 14.195

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.